HealthMine has created a free resource to help health plans improve their member engagement strategy. The Checklist for Effective Member Engagement contains everything you’ll need to ensure your member engagement initiatives are coordinated, scalable, and impactful. Whether you’re in the process of evaluating a member engagement vendor, or simply want a gut-check on your current strategy, this resource is here to help.
HealthMine is a quality improvement solution focused on empowering people to take the right actions related to their health. We build personalized, ongoing member engagement strategies for health plans in all lines of business that drive health actions through customized incentives and rewards and enhance member experience. To learn more, click here.
Bind Benefits, Inc. announced that its personalized health plan will be offered on a fully insured basis to Ohio employers with more than 50 employees. With Bind, employers have the opportunity to lower health care costs while giving their employees a rich benefit with a wide network and more health care decision-making power.
Ohio ranked 13th in the country for highest healthcare spending per person by state, according to a 2018 Health Care Cost Institute report. Ohioans who get their health insurance through work spent an average of $6,181 per person, higher than the national average of $5,892.
“Over the past two decades, there has been little innovation in health insurance. Employers need a better health insurance option and cost savings. They need a health benefit that gives their employees first-dollar coverage, clear choices and cost certainty. That is exactly what Bind delivers,” said Shawn Wagoner, Bind Chief Revenue Officer.
Bind personalized health plans allow people to see treatment options and compare costs in advance of care, flex coverage as needs change and eliminate the fuzzy math caused by deductibles and coinsurance. Bind has shown that when you give people tools to easily make informed decisions, they do.
To read more, click here.
Kiio has partnered with WPS Health Insurance, one of Wisconsin’s largest benefits providers, to offer digital musculoskeletal (MSK) care to its employees and self-insured employer groups. WPS chose Kiio for its customer-focused approach, proven clinical and financial outcomes, and depth of experience working with health plans.
“WPS is committed to providing solutions to our customers that both increase the quality of their lives and tackle the rising cost of health care,” says Dr. Jonah Fox, WPS Medical Director. “Kiio allows WPS to offer customers a simple, effective, evidence-based solution to prevent and manage musculoskeletal pain while also providing them with greater flexibility in how and where they receive care.”
Kiio CEO Lydia Zeller is enthusiastic about the outcomes WPS and Kiio will achieve in their collaboration. “Kiio values WPS’ dedication to its members’ care and its innovative approach to population health,” said Zeller. “We look forward to the impact WPS and Kiio can have in reducing pain, improving productivity, and curbing MSK costs in serving WPS’s employees and as a WPS benefit offered to self-funded employer groups.”
Click here to read more.
Kurome Therapeutics, a pre-clinical stage company dedicated to developing novel therapies that target adaptive resistance mechanisms in cancer cells while inhibiting critical disease modifying genes, has closed a $15 million Series A financing round. Medicxi and Affinity Asset Advisors co-led the funding round with participation from founding investor CincyTech, and other existing seed investors.
The company’s technology is based on research at Cincinnati Children’s Hospital Medical Center in collaboration with the National Institutes of Health’s National Center for Advancing Translational Sciences. To read more, click here.
Elligo Health Research has acquired Root Health, an AI virtual assistant for clinical research. The move is intended to support Elligo’s integrated research organization to improve the efficiency of clinical research and is designed to support easy access for faster enrollment and accelerated trials overall.
Elligo also added COO Miranda Mann Porter to its leadership team. Porter is an experienced global leader with a diverse background in therapeutics (CNS), operational execution of clinical development programs and Phase I-IV trials, post-marketing medical affairs services, and healthcare delivery.
Porter previously worked with Syneos Health where she rebuilt regional CRO leadership and infrastructure across 13 countries.
To read more, click here.
